{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:53:12Z","timestamp":1769637192652,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 12101532"],"award-info":[{"award-number":["No. 12101532"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Nos. 12001470"],"award-info":[{"award-number":["Nos. 12001470"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2021630"],"award-info":[{"award-number":["BE2021630"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Science and Technology Innovation Project of Xuzhou Health Commission","award":["XWKYHT20220158"],"award-info":[{"award-number":["XWKYHT20220158"]}]},{"name":"Leadership program through open competition in Xuzhou Medical University","award":["JBGS202203"],"award-info":[{"award-number":["JBGS202203"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["No. 2020M671607"],"award-info":[{"award-number":["No. 2020M671607"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of the Jiangsu Higher Education Institutions of China","award":["No. 21KJB110020"],"award-info":[{"award-number":["No. 21KJB110020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00415-023-12156-5","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T11:01:56Z","timestamp":1704366116000},"page":"2010-2018","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["An interactive web application to identify early Parkinsonian non-tremor-dominant subtypes"],"prefix":"10.1007","volume":"271","author":[{"given":"Xiaozhou","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiyun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lishun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"issue":"2","key":"12156_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3988\/jcn.2016.12.2.172","volume":"12","author":"LJ Zuo","year":"2016","unstructured":"Zuo LJ, Yu SY, Wang F et al (2016) Parkinson\u2019s Disease with Fatigue: Clinical Characteristics and Potential Mechanisms Relevant to \u03b1-Synuclein Oligomer. J Clin Neurol 12(2):172\u2013180. https:\/\/doi.org\/10.3988\/jcn.2016.12.2.172","journal-title":"J Clin Neurol"},{"key":"12156_CR2","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","volume":"40","author":"J Jankovic","year":"1990","unstructured":"Jankovic J, McDermott M, Carter J et al (1990) Variable expression of Parkinson\u2019s disease: A base-line analysis of the DAT ATOP cohort. Neurology 40:1529\u20131529. https:\/\/doi.org\/10.1212\/WNL.40.10.1529","journal-title":"Neurology"},{"key":"12156_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/ejn.14094","volume":"49","author":"JC Greenland","year":"2019","unstructured":"Greenland JC, Williams-Gray CH, Barker RA (2019) The clinical heterogeneity of Parkinson\u2019s disease and its therapeutic implications. Eur J Neurosci 49:328\u2013338. https:\/\/doi.org\/10.1111\/ejn.14094","journal-title":"Eur J Neurosci"},{"key":"12156_CR4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jamaneurol.2015.1067","volume":"72","author":"MC Schiess","year":"2015","unstructured":"Schiess MC, Suescun J (2015) Clinical Determinants of Progression of Parkinson Disease: Predicting Prognosis by Subtype. JAMA Neurol 72:859. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1067","journal-title":"JAMA Neurol"},{"key":"12156_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-023-02251-9","author":"F Nabizadeh","year":"2023","unstructured":"Nabizadeh F, Sodeifian F, Kargar A (2023) Cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in tremor-dominant Parkinson\u2019s disease. Acta Neurol Belg. https:\/\/doi.org\/10.1007\/s13760-023-02251-9","journal-title":"Acta Neurol Belg"},{"key":"12156_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/PL00007856","volume":"249","author":"T Foltynie","year":"2002","unstructured":"Foltynie T, Brayne C, Barker RA (2002) The heterogeneity of idiopathic Parkinson\u2019s disease. J Neurol 249:138\u2013145. https:\/\/doi.org\/10.1007\/PL00007856","journal-title":"J Neurol"},{"key":"12156_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/mds.20513","volume":"20","author":"GA Kang","year":"2005","unstructured":"Kang GA, Bronstein JM, Masterman DL et al (2005) Clinical characteristics in early Parkinson\u2019s disease in a central California population-based study. Mov Disord 20:1133\u20131142. https:\/\/doi.org\/10.1002\/mds.20513","journal-title":"Mov Disord"},{"issue":"5","key":"12156_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/ane.12893","volume":"137","author":"CJ Mao","year":"2018","unstructured":"Mao CJ, Xiong YT, Wang F et al (2018) Motor subtypes and other risk factors associated with drooling in Parkinson\u2019s disease patients. Acta Neurol Scand 137(5):509\u2013514. https:\/\/doi.org\/10.1111\/ane.12893","journal-title":"Acta Neurol Scand"},{"key":"12156_CR9","doi-asserted-by":"publisher","first-page":"6701519","DOI":"10.1155\/2022\/6701519","volume":"2022","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yang Y-W, Gu S-C et al (2022) (2022) The Importance of Early Identification for Parkinson\u2019s Disease Patients with Postural Instability and Gait Disturbance. Comput Intell Neurosci 2022:6701519. https:\/\/doi.org\/10.1155\/2022\/6701519","journal-title":"Comput Intell Neurosci"},{"issue":"3","key":"12156_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/ene.12476","volume":"22","author":"G Reinoso","year":"2015","unstructured":"Reinoso G, Allen JC Jr, Au WL, Seah SH, Tay KY, Tan LC (2015) Clinical evolution of Parkinson\u2019s disease and prognostic factors affecting motor progression: 9-year follow-up study. Eur J Neurol 22(3):457\u2013463. https:\/\/doi.org\/10.1111\/ene.12476","journal-title":"Eur J Neurol"},{"key":"12156_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JPD-202472","volume":"11","author":"TA Mestre","year":"2021","unstructured":"Mestre TA, Fereshtehnejad S-M, Berg D et al (2021) Parkinson\u2019s Disease Subtypes: Critical Appraisal and Recommendations. JPD 11:395\u2013404. https:\/\/doi.org\/10.3233\/JPD-202472","journal-title":"JPD"},{"key":"12156_CR12","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.scitotenv.2019.06.125","volume":"688","author":"I Lee","year":"2019","unstructured":"Lee I, Kim S, Park S et al (2019) Association of urinary phthalate metabolites and phenolics with adipokines and insulin resistance related markers among women of reproductive age. Sci Total Environ 688:1319\u20131326. https:\/\/doi.org\/10.1016\/j.scitotenv.2019.06.125","journal-title":"Sci Total Environ"},{"key":"12156_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3109\/00207454.2014.961454","volume":"125","author":"L Gao","year":"2015","unstructured":"Gao L, Tang H, Nie K et al (2015) Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson\u2019s disease diagnosis: a systematic review and meta-analysis. Int J Neurosci 125:645\u2013654. https:\/\/doi.org\/10.3109\/00207454.2014.961454","journal-title":"Int J Neurosci"},{"key":"12156_CR14","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00401-016-1552-2","volume":"131","author":"The Parkinson\u2019s Progression Marker","year":"2016","unstructured":"The Parkinson\u2019s Progression Marker Initiative, Kang J-H, Mollenhauer B, et al (2016) CSF biomarkers associated with disease heterogeneity in early Parkinson\u2019s disease: the Parkinson\u2019s Progression Markers Initiative study. Acta Neuropathol 131:935\u2013949. https:\/\/doi.org\/10.1007\/s00401-016-1552-2","journal-title":"Acta Neuropathol"},{"key":"12156_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","volume":"349","author":"T Tokuda","year":"2006","unstructured":"Tokuda T, Salem SA, Allsop D et al (2006) Decreased \u03b1-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson\u2019s disease. Biochem Biophys Res Commun 349:162\u2013166. https:\/\/doi.org\/10.1016\/j.bbrc.2006.08.024","journal-title":"Biochem Biophys Res Commun"},{"key":"12156_CR16","doi-asserted-by":"publisher","first-page":"1049118","DOI":"10.3389\/fnins.2022.1049118","volume":"16","author":"M Tao","year":"2022","unstructured":"Tao M, Dou K, Xie Y et al (2022) The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson\u2019s disease. Front Neurosci 16:1049118. https:\/\/doi.org\/10.3389\/fnins.2022.1049118","journal-title":"Front Neurosci"},{"key":"12156_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.parkreldis.2018.10.018","volume":"61","author":"T Schirinzi","year":"2019","unstructured":"Schirinzi T, Sancesario GM, Di Lazzaro G et al (2019) CSF \u03b1-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients. Parkinsonism Relat Disord 61:203\u2013206. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.10.018","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"12156_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"Parkinson Progression Marker Initiative","year":"2011","unstructured":"Parkinson Progression Marker Initiative (2011) The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 95(4):629\u2013635. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.09.005","journal-title":"Prog Neurobiol"},{"key":"12156_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00702-011-0736-0","volume":"119","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) CSF biomarkers in different phenotypes of Parkinson disease. J Neural Transm 119:455\u2013456. https:\/\/doi.org\/10.1007\/s00702-011-0736-0","journal-title":"J Neural Transm"},{"key":"12156_CR20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins GT, Goetz CG, Burn DJ et al (2013) How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: Comparison with the unified Parkinson\u2019s disease rating scale: PIGD and The MDS-UPDRS. Mov Disord 28:668\u2013670. https:\/\/doi.org\/10.1002\/mds.25383","journal-title":"Mov Disord"},{"key":"12156_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.artmed.2018.04.002","volume":"87","author":"S Sahran","year":"2018","unstructured":"Sahran S, Albashish D, Abdullah A et al (2018) Absolute cosine-based SVM-RFE feature selection method for prostate histopathological grading. Artif Intell Med 87:78\u201390. https:\/\/doi.org\/10.1016\/j.artmed.2018.04.002","journal-title":"Artif Intell Med"},{"key":"12156_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.24920\/004086","volume":"37","author":"C Wang","year":"2022","unstructured":"Wang C, Chang Q, Wang X et al (2022) Prostate Cancer Risk Prediction and Online Calculation Based on Machine Learning Algorithm. Chin Med Sci J 37:210","journal-title":"Chin Med Sci J"},{"key":"12156_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.975774","volume":"13","author":"Y Lai","year":"2022","unstructured":"Lai Y, Lin X, Lin C et al (2022) Identification of endoplasmic reticulum stress-associated genes and subtypes for prediction of Alzheimer\u2019s disease based on interpretable machine learning. Front Pharmacol 13:975774. https:\/\/doi.org\/10.3389\/fphar.2022.975774","journal-title":"Front Pharmacol"},{"key":"12156_CR24","doi-asserted-by":"publisher","first-page":"8737","DOI":"10.1007\/s00330-022-08887-0","volume":"32","author":"Y Wang","year":"2022","unstructured":"Wang Y, Lang J, Zuo JZ et al (2022) The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study. Eur Radiol 32:8737\u20138747. https:\/\/doi.org\/10.1007\/s00330-022-08887-0","journal-title":"Eur Radiol"},{"key":"12156_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jnnp-2012-303455","volume":"84","author":"C Marras","year":"2013","unstructured":"Marras C, Lang A (2013) Parkinson\u2019s disease subtypes: lost in translation? J Neurol Neurosurg Psychiatry 84:409\u2013415. https:\/\/doi.org\/10.1136\/jnnp-2012-303455","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12156_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.parkreldis.2019.06.017","volume":"65","author":"L Luo","year":"2019","unstructured":"Luo L, Andrews H, Alcalay RN et al (2019) Motor phenotype classification in moderate to advanced PD in BioFIND study. Parkinsonism Relat Disord 65:178\u2013183. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.017","journal-title":"Parkinsonism Relat Disord"},{"key":"12156_CR27","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1212\/WNL.0b013e318198db11","volume":"72","author":"E Tolosa","year":"2009","unstructured":"Tolosa E, Gaig C, Santamaria J, Compta Y (2009) Diagnosis and the premotor phase of Parkinson disease. Neurology 72:S12\u2013S20. https:\/\/doi.org\/10.1212\/WNL.0b013e318198db11","journal-title":"Neurology"},{"key":"12156_CR28","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1212\/WNL.0000000000004609","volume":"89","author":"B Mollenhauer","year":"2017","unstructured":"Mollenhauer B, Caspell-Garcia CJ, Coffey CS et al (2017) Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. Neurology 89:1959\u20131969. https:\/\/doi.org\/10.1212\/WNL.0000000000004609","journal-title":"Neurology"},{"key":"12156_CR29","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.ajpath.2013.12.007","volume":"184","author":"T Stewart","year":"2014","unstructured":"Stewart T, Liu C, Ginghina C et al (2014) Cerebrospinal Fluid \u03b1-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort. Am J Pathol 184:966\u2013975. https:\/\/doi.org\/10.1016\/j.ajpath.2013.12.007","journal-title":"Am J Pathol"},{"key":"12156_CR30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fneur.2018.00560","volume":"9","author":"M Dolatshahi","year":"2018","unstructured":"Dolatshahi M, Pourmirbabaei S, Kamalian A et al (2018) Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson\u2019s Disease. Front Neurol 9:560. https:\/\/doi.org\/10.3389\/fneur.2018.00560","journal-title":"Front Neurol"},{"key":"12156_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/mds.28941","volume":"37","author":"L Barba","year":"2022","unstructured":"Barba L, Paolini Paoletti F, Bellomo G et al (2022) Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers. Mov Disord 37:669\u2013683. https:\/\/doi.org\/10.1002\/mds.28941","journal-title":"Mov Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12156-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-12156-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12156-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:11:03Z","timestamp":1711548663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-12156-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["12156"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-12156-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"25 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The PPMI study has been approved by the respective institutional review boards of all participating sites, and written informed consents were obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}